2015 Controlled Substances FDA 
The Checkup by Singlecare
OCTOBER 4, 2023
That’s why you may have seen people talk about a medication called Vyvanse, which is FDA approved to treat ADHD and binge eating disorder, as a good option for weight loss. In 2015, the FDA approved Vyvanse to be used in the treatment of binge eating disorder. Does Vyvanse cause weight loss?
The Checkup by Singlecare
MAY 1, 2024
It is a Drug Enforcement Administration (DEA) controlled substance in the Schedule II category. Non-amphetamine-based ADHD treatments, such as Strattera , are not controlled substances. Food and Drug Administration (FDA) in 2007 for treatment and symptom control in ADHD.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The FDA Law Blog
MAY 7, 2023
As a reminder, back in February 2023, HPM blogged about DEA’s two proposed rules for prescribing controlled substances generally, and for buprenorphine use in opioid treatment. 1199, 1203 (2015) (“An agency must consider and respond to significant comments received during the period for public comment.”). 553). See Perez v.
The FDA Law Blog
FEBRUARY 27, 2024
156, a patent may be extended only once (even if it would be eligible for extension on more than one occasion because it applies to several FDA-approved products), and only one patent may be extended for each regulatory review period. This means that there multiple same-day FDA NDA approvals for the same drug. FDA-2020-E-1840 (Mar.
The Checkup by Singlecare
JANUARY 12, 2024
Key takeaways | Drug interactions | Food interactions | Other interactions | Avoiding interactions | When to see a doctor Tramadol, commonly known by the brand names Ultram and ConZip, is approved by the Food and Drug Administration (FDA) to treat moderate to severe pain.
The FDA Law Blog
FEBRUARY 7, 2024
Gilbert — Last week, DEA and DOJ announced a $59 million civil penalty settlement with eBay related to the failure to comply with Controlled Substances Act (CSA) requirements for identifying purchasers, maintaining records, and filing reports of individuals selling/purchasing pill presses and encapsulating machines. 21 U.S.C. §
The Checkup by Singlecare
JANUARY 15, 2024
Food and Drug Administration (FDA) as a treatment for narcolepsy. SSRIs are the most commonly prescribed type of antidepressant —and they are approved by the FDA for this purpose. Drescher notes that not every healthcare professional will feel comfortable prescribing certain controlled substances to patients with depression.
Expert insights. Personalized for you.
Let's personalize your content